Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:820816.
doi: 10.1155/2011/820816. Epub 2011 Jun 7.

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder

Affiliations

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder

Anastasios Athanasopoulos et al. Adv Urol. 2011.

Abstract

Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hashim H, Abrams P. Overactive bladder: an update. Current Opinion in Urology. 2007;17(4):231–236. - PubMed
    1. Andersson K-E. Antimuscarinic mechanisms and the overactive detrusor: an update. European Urology. 2011;59(3):377–386. - PubMed
    1. Yamaguchi O. Antimuscarinics and overactive bladder: other mechanism of action. Neurourology and Urodynamics. 2010;29(1):112–115. - PubMed
    1. Giglio D, Tobin G. Muscarinic receptor subtypes in the lower urinary tract. Pharmacology. 2009;83(5):259–269. - PubMed
    1. Andersson KE, Chappie CR. Oxybutynin and the overactive bladder. World Journal of Urology. 2001;19(5):319–323. - PubMed

LinkOut - more resources